TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT06583096

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Surveys
Description: Participants (in both arms) will complete surveys once per week and participants in the intervention arm will also complete additional 1-minute surveys daily. Study participation will be completed at the conclusion of the final follow-up survey administered 6-weeks after study enrollment.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Surveys
Description: Participants (in both arms) will complete surveys once per week and participants in the intervention arm will also complete additional 1-minute surveys daily. Study participation will be completed at the conclusion of the final follow-up survey administered 6-weeks after study enrollment.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Supportive Text messages
Description: Text messages will be sent Mondays-Sunday if participants are randomized to receive them in a given week, with a daily 50:50 send/no-send randomization. A bank of 25 text messages will be used for the study, providing tips/strategies across a range of topics, including managing time and academic stressors, recommendations for self-care and mood management, and messages geared towards fostering social connections and support. Some messages will contain links to videos, websites, or articles for more information on a topic.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Personalized Feedback (PF) Report
Description: For individuals that are randomized to receive a Personalized Feedback Report, the study team will send participants a text on a Monday with the feedback from the prior survey (baseline survey in the first week, weekly survey in the next five weeks). There will be graphs for depression, anxiety, stress, and flourishing.
Study: NCT06537518

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bupivacaine 0.5% Injectable Solution
Description: 20 ml of Bupivacain 0.5% was mixed with dexamethasone 8 mg is injected into the adductor canal deeply to the sartorius muscle around the saphenous nerve after ensuring negative aspiration space.
Study: NCT05064969

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Blended intervention based in acceptance and commitment therapy
Description: Blended intervention includes completing 9 e-modules consist of written material, videos, and assignments (one e-module per week) that can be completed over 9 to 12 weeks AND 9 (to 12 ) coaching sessions (telephone call). Weekly coaching will be offered by a motivational coach based in Maastricht University.~After the post-intervention assessments, individuals will receive monthly calls from the motivational coach as booster sessions. Booster sessions will be received on monthly basis for a period of 6 months (one session per month) and until the last follow-up assessment. Communication with participants will take place online or via telephone.
Study: NCT05938634

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Stage-matched interventions
Description: Precontemplation-based intervention Contemplation-based intervention Preparation-based intervention Action-based intervention Maintenance-based intervention

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Stage-matched interventions
Description: Precontemplation-based intervention Contemplation-based intervention Preparation-based intervention Action-based intervention Maintenance-based intervention

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Stage-matched interventions
Description: Precontemplation-based intervention Contemplation-based intervention Preparation-based intervention Action-based intervention Maintenance-based intervention

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Stage-matched interventions
Description: Precontemplation-based intervention Contemplation-based intervention Preparation-based intervention Action-based intervention Maintenance-based intervention

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Stage-matched interventions
Description: Precontemplation-based intervention Contemplation-based intervention Preparation-based intervention Action-based intervention Maintenance-based intervention
Study: NCT05146869

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DBPR108 tablets
Description: DBPR108 tablets, oral, once daily on Day 1 and Day 3-9 for a total of 8 doses.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DBPR108 tablets
Description: DBPR108 tablets, oral, once daily on Day 1 and Day 3-9 for a total of 8 doses.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DBPR108 tablets
Description: DBPR108 tablets, oral, once daily on Day 1 and Day 3-9 for a total of 8 doses.
Study: NCT05394558

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: AsiDNA
Description: Administration of AsiDNA followed by radiotherapy

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AsiDNA
Description: Administration of AsiDNA followed by radiotherapy
Study: NCT06109038

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Conventional PT + ITB release with graston technique
Description: An emollient will be applied to the leg from the lateral joint line along the tibial condyle to just below the iliac crest. The instrument GT-4 will be used for treatment. The tool was used to assess the soft tissue in three locations on the lateral leg: anterior to the ITB, over the ITB, and posterior to the ITB. Brushing and strumming strokes were performed to the tissue utilising the instrument's convex surface. Treatment time with the instrument is 8 -10 mins .~Conventional PT including Hot Pack for 5mins. Quadriceps setting exercises, short arc terminal knee extension, straight leg raise, ROM exercises, hamstring curls in prone lying position, quadriceps strengthening in high sitting position, gastrocnemius muscle stretching (10reps × 5sec × 2sets). Maitland mobilization (Grade 1, 2 and 3 for 10 repetitions).

Intervention type: OTHER
Group type: OTHER
Intervention: Conventional PT
Description: Conventional PT including Hot Pack for 5mins. Quadriceps setting exercises, short arc terminal knee extension, straight leg raise, ROM exercises, hamstring curls in prone lying position, quadriceps strengthening in high sitting position, gastrocnemius muscle stretching (10reps × 5sec × 2sets). Maitland mobilization (Grade 1, 2 and 3 for 10 repetitions).
Study: NCT05972720

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fludarabine (Conditional therapy)
Description: Lymphodepletion chemotherapy

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fludarabine (Conditional therapy)
Description: Lymphodepletion chemotherapy

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fludarabine (Conditional therapy)
Description: Lymphodepletion chemotherapy

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide Monohydrate (Conditional therapy)
Description: Lymphodepletion chemotherapy

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide Monohydrate (Conditional therapy)
Description: Lymphodepletion chemotherapy
Study: NCT06248034

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Smartphone application with tele-monitoring rehabilitation
Description: This Smartphone application includes an automated criterion-based progression based on participant's regular recorded self-measurement of knee range-of-motion and five-repetition-sit-to-stand. The rehabilitation program is designed to (i) increase knee range-of-motion, (ii) strengthen lower limb strength, (iii) improve postural balance, and (iv) improve physical function.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Hospital-based rehabilitation program
Description: Participants will be provided with the usual preoperative, inpatient physiotherapy and a physiotherapy house visit within the first 2-weeks postoperation. Participants will receive exercises, patient education, manual therapy and other modalities that were prescribed and progressed at the project physiotherapist's discretion.
Study: NCT06255288

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: SNAK intervention
Description: The intervention consists of structured dialogue, patient information, and a protein supplement. The structured dialogue part of the intervention consists of an A3 poster with illustrations and keywords which will be hanging in the outpatient clinics. The poster will be utilized by nurses, patients, and their relatives to facilitate a dialogue regarding nutrition and wound healing. The patient information part of the intervention consists of a leaflet with easy-to-read information, which patients and their relatives can bring home after their visit to the outpatient clinic. The leaflet will consist of general information as well as food categories and recipes they can use to enhance their daily protein intake. For the protein supplement part of the intervention, the patients will have access to protein supplement beverages while they are in the outpatient clinic waiting room. Furthermore, they will receive prescriptions for protein drinks, that they can pick up at their local pharmacy.
Study: NCT05043428

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: The roles of peers and functional tasks in enhancing exercise training for adults with COPD: a pilot randomized controlled trial
Description: An 8 week two-arm pilot randomized control trial aimed to evaluate the effects of an online exercise and peer support intervention for people living with COPD.
Study: NCT04796532

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Home based HIIT
Description: Intervention will consist in a 16-week exercise program with HIIT with a frequency of 3 days/week. The Home-HIIT group participants will attend HIIT workout sessions supervised by a specialised instructor via a videoconference application. Every HIIT workout session will have a 10 minutes' warm-up, followed by an 8/12/16/20 minutes of HIIT (stages of physical adaptation every 4 weeks) training and 5 minutes' cool-down. Tabata method will be used with eight sets of 20 seconds of exercise bouts separated by 10 seconds rest, in 2 to 5 blocks. The intervention will have four stages of physical adaptation.~This group will have a follow-up period of 16 weeks.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Traditional HIIT
Description: Intervention will consist in a 16-week exercise program with HIIT with a frequency of 3 days/week. The Traditional HIIT group participants will attend a group HIIT workout sessions supervised by a specialised instructor in a sport facility. Every HIIT workout session will have a 10 minutes' warm-up, followed by an 8/12/16/20 minutes of HIIT (stages of physical adaptation every 4 weeks) training and 5 minutes' cool-down. Tabata method will be used with eight sets of 20 seconds of exercise bouts separated by 10 seconds rest, in 2 to 5 blocks. The intervention will have four stages of physical adaptation.~This group will have a follow-up period of 16 weeks.
Study: NCT05972720

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide Monohydrate (Conditional therapy)
Description: Lymphodepletion chemotherapy

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: firi-cel (Experimental drug)
Description: Investigational agent

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: firi-cel (Experimental drug)
Description: Investigational agent

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: firi-cel (Experimental drug)
Description: Investigational agent
Study: NCT04386681

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Reentry Continuum for Brain Injury (RCBI)
Description: Pre-Release RCBI Treatment Procedures (BICS and ICAN). BICS: consists of 12 weekly two- hour sessions. Sessions focus on brain injury education, coping skills for the various symptoms of brain injury, depression management, stress management, and self- advocacy.~ICAN: delivered once a week for 6 weeks for 2 hours per session. ICAN primarily focuses on poor perspective-taking and inability to make social inferences about others' behaviors that are related to negative attributions, and employs role playing exercises and a novel perspective-positioning technique to elicit affective and cognitive empathy to alter negative attributions and reduce anger.~Post-Release RCBI Resource Facilitation. Working with their resource facilitator, alongside their corrections case manager, to work on brain injury specific reentry planning, resource, and needs identification.
Study: NCT05997238

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: without triamcinolone
Description: The preparation contains only the basic formula. The base formula contains 150mg ropivacaine and 0.5mg epinephrine. Add normal saline and mix to 80ml.
Study: NCT05043428

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: The roles of peers and functional tasks in enhancing exercise training for adults with COPD: a pilot randomized controlled trial
Description: An 8 week two-arm pilot randomized control trial aimed to evaluate the effects of an online exercise and peer support intervention for people living with COPD.
Study: NCT05837065

Intervention type: OTHER
Intervention: observing whether HCC patients having tumor micronecrosis
Description: whether HCC patients having tumor micronecrosis or not

Intervention type: OTHER
Intervention: observing whether HCC patients having tumor micronecrosis
Description: whether HCC patients having tumor micronecrosis or not
Study: NCT04684784

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Intervention-Dry Needling
Description: Deep Dry Needling into the site of the latent TriggerPoint of the upper trapezius muscle. 1 session in upper trapezius muscle moving the needle up and down ten times.

Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Control-Dry Needling
Description: Sham Dry Needling into the site of the latent Trigger Point of the upper trapezius muscle with non-penetrating needles
Study: NCT05997238

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 20mg triamcinolone
Description: 20mg triamcinolone was added to the preparation. Mix 20mg triamcinolone and the basic formula to make a mixed preparation. The base formula contains 150mg ropivacaine and 0.5mg epinephrine. Add normal saline and mix to 80ml.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 40mg triamcinolone
Description: 40mg triamcinolone was added to the preparation. Mix 40mg triamcinolone and the basic formula to make a mixed preparation. The base formula contains 150mg ropivacaine and 0.5mg epinephrine. Add normal saline and mix to 80ml.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 80mg triamcinolone
Description: 80mg triamcinolone was added to the preparation. Mix 80mg triamcinolone and the basic formula to make a mixed preparation. The base formula contains 150mg ropivacaine and 0.5mg epinephrine. Add normal saline and mix to 80ml.
Study: NCT05522803

Intervention type: DEVICE
Group type: OTHER
Intervention: TMS followed by sham TMS
Description: Transcranial Magnetic Stimulation followed by sham TMS
Study: NCT05088824

Intervention type: PROCEDURE
Intervention: hernia repair by desarda technique
Description: It involves use of undetached strip of external oblique aponeurosis to strengthen the posterior wall of the inguinal canal which is based on the physiological principles. This is a physiological repair and is tension free, can be used in strangulated hernia
Study: NCT05649982

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: ALVA
Description: Behavioural digital self-help intervention

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: ALVA
Description: Behavioural digital self-help intervention

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: ALVA
Description: Behavioural digital self-help intervention

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: ALVA
Description: Behavioural digital self-help intervention
Study: NCT05522803

Intervention type: DEVICE
Group type: OTHER
Intervention: Sham TMS followed by TMS
Description: Sham Transcranial Magnetic Stimulation followed by TMS
Study: NCT06634992

Intervention type: OTHER
Intervention: Oral immunotherapy
Description: Clinical Follow up

Intervention type: OTHER
Intervention: Oral immunotherapy
Description: Clinical Follow up
Study: NCT05325008

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Immunosuppression reduction/modification + intravenous immunoglobulin
Description: Participants will receive intravenous immunoglobulin along with immunosuppression reduction/modification.

Intervention type: OTHER
Group type: OTHER
Intervention: Immunosuppression reduction/modification
Description: Participants will receive immunosuppression reduction/modification.
Study: NCT05935098

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BGB-A3055
Description: Administered intravenously
Study: NCT06634992

Intervention type: OTHER
Intervention: Oral immunotherapy
Description: Clinical Follow up
Study: NCT06635382

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Universal single bond adhesive
Description: Will be applied and light cured for 20 seconds.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Universal single bond adhesive
Description: Will be applied and light cured for 20 seconds.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: DMSO
Description: DMSO application on tooth followed by active application of universal single bond adhesive and light cured for 20 seconds.
Study: NCT04797858

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: COVID-19 self-test
Description: 5 COVID-19 self-test kits will be given to participants after they have been tested for COVID-19. Participants will be instructed to give test kits to others in their social networks who are symptomatic, exposed to COVID-19, or otherwise at high risk of COVID-19.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: COVID-19 test referral
Description: 5 test referral cards and text messages on how to obtain COVID-19 testing will be given to participants after they have been tested for COVID-19. These cards and text messages will have information on how to obtain free COVID-19 tests at local testing sites. Participants will be instructed to give out referral cards and text messages to others in their social networks to obtain testing.
Study: NCT05559216

Intervention type: OTHER
Group type: OTHER
Intervention: Plyometric Training
Description: Plyometric training exercises are being given to the participants to see the changes after the 8 week period
Study: NCT06155799

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Freehand zygomatic implant placement
Description: Zygomatic implants will be placed without any guidance after preoperative virtual planning has been performed.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Freehand zygomatic implant placement
Description: Zygomatic implants will be placed without any guidance after preoperative virtual planning has been performed.
Study: NCT05399719

Intervention type: OTHER
Description: no intervention

Intervention type: OTHER
Description: no intervention
Study: NCT06176859

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: HIV PrEP Delivery
Description: To test an end-to-end decentralized delivery service for pre-exposure prophylaxis (PrEP) to safely increase PrEP access and use among priority populations in South Africa.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: HIV PrEP Delivery
Description: To test an end-to-end decentralized delivery service for pre-exposure prophylaxis (PrEP) to safely increase PrEP access and use among priority populations in South Africa.
Study: NCT05085860

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Moderate-intensity continuous training (MICT)
Description: Participants will engage in exercise and record AF symptoms prospectively over 7 days

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: High-intensity interval training (HIIT)
Description: Participants will engage in exercise and record AF symptoms prospectively over 7 days
Study: NCT05580926

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Watch your Weight During Holidays
Description: Participants in this group will have an individual face-to-face session (with a maximum duration of half an hour) and a face-to-face group session. This intervention will include strategies for self-monitoring (body weight, diet and physical activity), information on healthy lifestyles, as well as information about the energy contained in local festive foods and their equivalent in minutes of physical activity or steps per day.~Participants will be asked to weight themselves at least twice a week, as a form of self-monitoring of weight, from the start of the intervention. They will have access to weekly forms with boxes, where they can fill in the data obtained for each day of weight self-monitoring, energy intake restriction report and minutes of physical activity performed.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Control Group (minimal intervention)
Description: Participants in this group will receive a printed information, as well as a PDF file, brochure during a face-to-face session at the beginning of the 8-week period. This information will be about having a healthy eating based on the norm for health promotion and education for healthy eating in Mexico (NOM-043-SSA2-2012).
Study: NCT05068206

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AK105 injection
Description: AK105 is programmed death 1（PD-1） monoclonal antibody

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Anlotinib hydrochloride capsule
Description: Anlotinib is small molecule multi-target tyrosine kinase inhibitor.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Anlotinib hydrochloride capsule
Description: Anlotinib is small molecule multi-target tyrosine kinase inhibitor.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CapeOX
Description: CapeOX is Capecitabine+Oxaliplatin. Capecitabine is a kind of fluorouracil drug, and Oxaliplatin is a kind of platinum anticancer drug.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CapeOX
Description: CapeOX is Capecitabine+Oxaliplatin. Capecitabine is a kind of fluorouracil drug, and Oxaliplatin is a kind of platinum anticancer drug.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: CapeOX
Description: CapeOX is Capecitabine+Oxaliplatin. Capecitabine is a kind of fluorouracil drug, and Oxaliplatin is a kind of platinum anticancer drug.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bevacizumab
Description: Bevacizumab is a recombinant human monoclonal antibody.
Study: NCT06356870

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: BMAC MIXED WITH ALLOGRAFT
Description: Study group

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Cancellous bone from anterior iliac crest
Description: Control group